Drugs: From Discovery to Approval / Edition 2

Hardcover (Print)
Rent from BN.com
(Save 72%)
Est. Return Date: 07/26/2015
Used and New from Other Sellers
Used and New from Other Sellers
from $55.55
Usually ships in 1-2 business days
(Save 51%)
Other sellers (Hardcover)
  • All (10) from $55.55   
  • New (6) from $85.70   
  • Used (4) from $55.55   


The new edition of this bestselling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.
Read More Show Less

Editorial Reviews

From the Publisher
"Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs." (Doody's Reviews, May 2009)

"This textbook provides the reader with a high-level overview of the drug discovery process and the regulatory challenges facing the journey from drug molecule to marketplace." (The Pharmaceutical Journal, March 2009)

"The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials." (Chemistry World, February 2009)

Doody's Review Service
Reviewer: Michael R Jacobs, BS, PharmD (Temple University School of Pharmacy)
Description: This is the second edition of a book, first published in 2004, that provides an overview of how drugs are discovered and the path that a compound takes on its way to final approval for human use. Each chapter contains a case study, review questions and answers, and a summary of important points. The book includes a number of "exhibits" designed to expand and clarify specific issues to assist readers by providing a context or application for the information in certain sections. The exhibits vary substantially in meeting this goal. Also included are nine appendixes, a list of acronyms, a glossary, and an index.
Purpose: While the objective of providing an overview of the drug approval process is worthy, it is also a monumental undertaking. The breadth of topics covered is substantial and includes the basics of drug-receptor interactions, small and large molecule drug discovery, preclinical testing, clinical trials, regulatory issues, and good manufacturing practices. Volumes have been written on each of these topics; consequently the depth to which they are covered in this book is limited. Even so, the author has provided the promised overview.
Audience: The book is intended for academic and industry researchers and healthcare policy makers, as well as students in the health professions. It may be most useful for individuals unfamiliar with the complexities of the drug development process and those who may work in the pharmaceutical industry who would like to understand the challenges outside of their own area of expertise. The author has over 25 years of experience in the pharmaceutical industry in managerial positions.
Features: The book lays the groundwork with the basics of drug-receptor interactions and brief discussions of potential drug targets such as various enzymes. Thereafter, animal studies and other preclinical testing are described, followed by a review of the various phases of human trials. Regulatory authorities (i.e. the ministries and agencies that regulate drug development) and regulatory applications (how drugs are approved) are addressed in two separate chapters and might have been combined. The information provided about regulatory authorities is somewhat unbalanced, with nearly four pages devoted to the U.S. FDA while the Canadian system, Health Canada, is covered in a single paragraph. The glossary has fewer than 100 entries and it is unclear why some were selected for inclusion (such as otitis media and re-stenosis), which have little to do with the general drug discovery process itself. The nine appendixes vary considerably in their relevance to the drug development process. For example, one appendix contains 27 "selected" drugs, their class, and mechanisms of action. In this section, antagonist and blocker are used interchangeably, and the mechanisms of action are not always very descriptive ("diazepam acts as a central nervous system depressant"). Furthermore, some of the information is duplicated in Table 2.4. The general biomarkers appendix lists common laboratory tests, which does not reflect the current use of this phrase, and the acronyms do not always relate to drug development (e.g. TM = traditional medicine and IOC = International Olympic Committee). The book contains more misspellings than I am accustomed to seeing, inconsistencies in the information presented (figures depicting drug movement through the body), oversimplification of some concepts (time-concentration curves), and some misinformation (albuterol described as a beta-2 antagonist).
Assessment: The author took on a substantial challenge in writing this book. Several books would be required to cover the breadth of material available here. However, it does serve the purpose of revealing to those outside of the pharmaceutical industry the complexities of bringing a drug to market. Those more familiar with drug development may find only certain chapters outside of their area of expertise to be useful. Rapid changes in drug development technology support the need for a second edition.
Read More Show Less

Product Details

  • ISBN-13: 9780470195109
  • Publisher: Wiley
  • Publication date: 11/24/2008
  • Edition description: New Edition
  • Edition number: 2
  • Pages: 480
  • Sales rank: 669,907
  • Product dimensions: 6.40 (w) x 9.30 (h) x 1.00 (d)

Meet the Author

Rick Ng, PhD, MBA, has worked for more than 25 years in senior management positions in the private sector pharmaceutical industry. He is currently providing consulting services to the pharmaceutical industry and training for graduates, postgraduates, and pharmaceutical professionals at the National University of Singapore and the University of New South Wales, Australia.
Read More Show Less

Table of Contents

Ch. 1 Introduction 1
Ch. 2 Drug Discovery: Targets and Receptors 15
Ch. 3 Drug Discovery: Small Molecule Drugs 43
Ch. 4 Drug Discovery: Large Molecule Drugs 75
Ch. 5 Drug Development and Preclinical Studies 107
Ch. 6 Clinical Trial 139
Ch. 7 Regulatory Authorities 159
Ch. 8 Regulatory Applications 175
Ch. 9 Good Manufacturing Practice: Regulatory Requirements 211
Ch. 10 Good Manufacturing Practice: Drug Manufacturing 247
Ch. 11 Future Perspectives 281
App. 1 History of Drug Discovery and Development 305
App. 2 Cells, Nucleic Acids, Genes and Proteins 313
App. 3 Selected Drugs and Their Mechanisms of Action 327
App. 4 Pharmacology/Toxicology Review Format 329
Acronyms 335
Glossary 339
Index 347
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)